EUR 32.28
(1.22%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 17.32 Million USD | -47.98% |
2022 | 33.29 Million USD | 21.12% |
2021 | 27.49 Million USD | 31.09% |
2020 | 20.97 Million USD | 62.76% |
2019 | 12.88 Million USD | 30.98% |
2018 | 9.83 Million USD | 47.78% |
2017 | 6.65 Million USD | 99.43% |
2016 | 3.33 Million USD | 27.6% |
2015 | 2.61 Million USD | 9.87% |
2014 | 2.38 Million USD | -17.61% |
2013 | 2.89 Million USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | -100.0% |
2006 | 6.08 Million USD | 11.76% |
2005 | 5.44 Million USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | -100.0% |
2000 | 3.61 Million USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 21.1 Million USD | 21.84% |
2023 Q3 | 24.97 Million USD | -12.77% |
2023 Q1 | 29.9 Million USD | -10.18% |
2023 Q2 | 28.63 Million USD | -4.26% |
2023 Q4 | 17.32 Million USD | -30.65% |
2023 FY | 17.32 Million USD | -47.98% |
2022 Q3 | 26.71 Million USD | -19.11% |
2022 Q2 | 33.02 Million USD | 15.99% |
2022 Q1 | 28.46 Million USD | 3.54% |
2022 Q4 | 33.29 Million USD | 24.66% |
2022 FY | 33.29 Million USD | 21.12% |
2021 Q3 | 28.24 Million USD | 13.04% |
2021 Q4 | 27.49 Million USD | -2.65% |
2021 Q2 | 24.98 Million USD | 0.91% |
2021 FY | 27.49 Million USD | 31.09% |
2021 Q1 | 24.75 Million USD | 18.04% |
2020 Q2 | 16.6 Million USD | 7.73% |
2020 Q1 | 15.41 Million USD | 19.64% |
2020 FY | 20.97 Million USD | 62.76% |
2020 Q3 | 19.31 Million USD | 16.32% |
2020 Q4 | 20.97 Million USD | 8.56% |
2019 Q1 | 10.14 Million USD | 3.1% |
2019 Q2 | 12.35 Million USD | 21.78% |
2019 FY | 12.88 Million USD | 30.98% |
2019 Q3 | 13.36 Million USD | 8.21% |
2019 Q4 | 12.88 Million USD | -3.59% |
2018 Q2 | 8.37 Million USD | 10.68% |
2018 FY | 9.83 Million USD | 47.78% |
2018 Q4 | 9.83 Million USD | -5.7% |
2018 Q3 | 10.43 Million USD | 24.63% |
2018 Q1 | 7.56 Million USD | 13.61% |
2017 Q2 | 5.42 Million USD | 64.19% |
2017 FY | 6.65 Million USD | 99.43% |
2017 Q4 | 6.65 Million USD | 14.66% |
2017 Q3 | 5.8 Million USD | 7.02% |
2017 Q1 | 3.3 Million USD | -1.02% |
2016 Q3 | 3.29 Million USD | 17.24% |
2016 Q4 | 3.33 Million USD | 1.4% |
2016 Q1 | 2.47 Million USD | -5.5% |
2016 Q2 | 2.8 Million USD | 13.59% |
2016 FY | 3.33 Million USD | 27.6% |
2015 Q2 | 2.6 Million USD | 0.58% |
2015 Q3 | 2.12 Million USD | -18.67% |
2015 Q4 | 2.61 Million USD | 23.34% |
2015 Q1 | 2.59 Million USD | 8.9% |
2015 FY | 2.61 Million USD | 9.87% |
2014 FY | 2.38 Million USD | -17.61% |
2014 Q4 | 2.38 Million USD | -38.57% |
2014 Q1 | 2.68 Million USD | -7.06% |
2014 Q3 | 3.87 Million USD | 28.09% |
2014 Q2 | 3.02 Million USD | 12.66% |
2013 Q1 | 280 Thousand USD | 0.0% |
2013 FY | 2.89 Million USD | 0.0% |
2013 Q4 | 2.89 Million USD | 63.83% |
2013 Q3 | 1.76 Million USD | 159.03% |
2013 Q2 | 681 Thousand USD | 143.21% |
2012 Q3 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2007 FY | - USD | -100.0% |
2007 Q4 | - USD | -100.0% |
2007 Q3 | 9.75 Million USD | 2.92% |
2007 Q2 | 9.47 Million USD | 0.0% |
2007 Q1 | - USD | -100.0% |
2006 Q2 | 6.15 Million USD | 24.26% |
2006 Q1 | 4.95 Million USD | -9.02% |
2006 Q4 | 6.08 Million USD | -18.93% |
2006 FY | 6.08 Million USD | 11.76% |
2006 Q3 | 7.5 Million USD | 21.94% |
2005 Q2 | 5.89 Million USD | 0.0% |
2005 Q3 | 7.14 Million USD | 21.22% |
2005 Q1 | - USD | 0.0% |
2005 FY | 5.44 Million USD | 0.0% |
2005 Q4 | 5.44 Million USD | -23.79% |
2004 Q4 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 FY | - USD | -100.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | -100.0% |
2000 FY | 3.61 Million USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 Q4 | 3.61 Million USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
BioNTech SE | 357.7 Million EUR | 95.157% |
CureVac N.V. | 24.82 Million EUR | 30.21% |
Biotest Aktiengesellschaft | 419.1 Million EUR | 95.867% |
Biotest Aktiengesellschaft | 419.1 Million EUR | 95.867% |
BRAIN Biotech AG | 9.72 Million EUR | -78.11% |
Formycon AG | 467 Thousand EUR | -3609.422% |
Heidelberg Pharma AG | 10.48 Million EUR | -65.173% |
Medigene AG | 1.00 EUR | -1732299900.0% |